Galectin-3 Knockdown Impairs Survival, Migration, and Immunomodulatory Actions of Mesenchymal Stromal Cells in a Mouse Model of Chagas Disease Cardiomyopathy

Galectin-3 Knockdown Impairs Survival, Migration, and Immunomodulatory Actions of Mesenchymal Stromal Cells in a Mouse Model of Chagas Disease Cardiomyopathy

Therapies based on transplantation of mesenchymal stromal cells (MSC) hold promise for the management of inflammatory disorders. In chronic Chagas disease cardiomyopathy (CCC), caused by chronic infection with Trypanosoma cruzi, the exacerbated immune response plays a critical pathophysiological rol...

Full description

Bibliographic Details
Main Authors:	Bruno Solano de Freitas Souza, Kátia Nunes da Silva, Daniela Nascimento Silva, Vinícius Pinto Costa Rocha, Bruno Diaz Paredes, Carine Machado Azevedo, Carolina Kymie Nonaka, Gisele Batista Carvalho, Juliana Fraga Vasconcelos, Ricardo Ribeiro dos Santos, Milena Botelho Pereira Soares
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	Stem Cells International
Online Access:	http://dx.doi.org/10.1155/2017/3282656

Similar Items

IGF-1-Overexpressing Mesenchymal Stem/Stromal Cells Promote Immunomodulatory and Proregenerative Effects in Chronic Experimental Chagas Disease
by: Daniela N. Silva, et al.
Published: (2018-01-01)

Granulocyte-Colony Stimulating Factor-Overexpressing Mesenchymal Stem Cells Exhibit Enhanced Immunomodulatory Actions Through the Recruitment of Suppressor Cells in Experimental Chagas Disease Cardiomyopathy
by: Daniela N. Silva, et al.
Published: (2018-06-01)

Therapeutic effects of sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy
by: Juliana Fraga Vasconcelos, et al.
Published: (2017-07-01)

Assessment of Galectin-3 Polymorphism in Subjects with Chronic Chagas Disease
by: Gabriela da Silva Cruz, et al.
Published: (2015-11-01)

Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy
by: Carolina Kymie Vasques Nonaka, et al.
Published: (2019-08-01)

Immunomodulatory Effects of Mesenchymal Stromal Cells Revisited in the Context of Inflammatory Cardiomyopathy
by: Kapka Miteva, et al.
Published: (2013-01-01)

Tolerogenic Dendritic Cells Reduce Cardiac Inflammation and Fibrosis in Chronic Chagas Disease
by: Emanuelle de Souza Santos, et al.
Published: (2020-04-01)

Betulinic Acid Derivative BA5, Attenuates Inflammation and Fibrosis in Experimental Chronic Chagas Disease Cardiomyopathy by Inducing IL-10 and M2 Polarization
by: Cássio Santana Meira, et al.
Published: (2019-06-01)

Assessment of syndecan-4 expression in the hearts of Trypanosoma cruzi-infected mice and human subjects with chronic Chagas disease cardiomyopathy
by: Ticiana Ferreira Larocca, et al.
Published: (2018-12-01)

Chronic Chagas cardiomyopathy
by: Vera Demarchi Aiello, et al.
Published: (2015-09-01)

Treatment of Chagas Cardiomyopathy
by: Fernando A. Botoni, et al.
Published: (2013-01-01)

Therapeutic miR-21 Silencing Reduces Cardiac Fibrosis and Modulates Inflammatory Response in Chronic Chagas Disease
by: Carolina Kymie Vasques Nonaka, et al.
Published: (2021-03-01)

The Immunomodulatory Role of Galectin-3 in Innate Immune Response to Fungal Infection
by: Sheng-Yang Wu, et al.
Published: (2016)

Clinical Presentations of Chagas Cardiomyopathy
by: Malik Shehadeh, et al.
Published: (2020-01-01)

Heart transplantation for Chagas cardiomyopathy
by: Ana Rita Ramalho, et al.
Published: (2017-11-01)

Heart transplantation for Chagas cardiomyopathy
by: Ana Rita Ramalho, et al.
Published: (2017-11-01)

Chagas Disease Cardiomyopathy: Immunopathology and Genetics
by: Edecio Cunha-Neto, et al.
Published: (2014-01-01)

Cardiac Chagas Disease: MMPs, TIMPs, Galectins, and TGF-β as Tissue Remodelling Players
by: Arthur Wilson Florencio da Costa, et al.
Published: (2019-01-01)

The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells
by: Haiping He, et al.
Published: (2021-08-01)

IMMUNOMODULATORY ACTIVITY OF MESENCHIMAL STROMAL (STEM) CELLS
by: V. B. Klimovich
Published: (2014-08-01)

Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update
by: Luise Müller, et al.
Published: (2021-02-01)

The Immunomodulatory Potential of Wharton’s Jelly Mesenchymal Stem/Stromal Cells
by: Fernanda Vieira Paladino, et al.
Published: (2019-01-01)

Immunomodulatory Role of Tenascin-C in Myocarditis and Inflammatory Cardiomyopathy
by: Kazuko Tajiri, et al.
Published: (2021-02-01)

Chagas cardiomyopathy in the context of the chronic disease transition.
by: Alicia I Hidron, et al.
Published: (2010-05-01)

Cognitive dysfunction in chronic Chagas disease cardiomyopathy
by: Jesângeli Sousa Dias, et al.

Immune exhaustion in chronic Chagas disease: Pro-inflammatory and immunomodulatory action of IL-27 in vitro.
by: María Ailén Natale, et al.
Published: (2021-06-01)

Echocardiographic parameters associated with pulmonary congestion in outpatients with Chagas' cardiomyopathy and non-chagasic cardiomyopathy
by: Marselha Marques Barral, et al.
Published: (2012-04-01)

Chronic Chagas Cardiomyopathy Patients and Resynchronization Therapy: a Survival Analysis
by: Antônio da Silva Menezes Junior, et al.

Chagas cardiomyopathy and heart failure: From epidemiology to treatment
by: Érico Santos, et al.
Published: (2020-05-01)

Chagas cardiomyopathy and heart failure: From epidemiology to treatment
by: Érico Santos, et al.
Published: (2020-05-01)

The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy
by: Walace de Souza Pimentel, et al.
Published: (2012-09-01)

Imaging Diagnosis of Right Ventricle Involvement in Chagas Cardiomyopathy
by: Minna M. D. Romano, et al.
Published: (2017-01-01)

Left Ventricular Assist Device as a Bridge to Candidacy in End-stage Chagas Cardiomyopathy
by: Fernando Antibas Atik, et al.

Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility
by: Heidi L. Reesink, et al.
Published: (2017-11-01)

Parasitic Load Correlates With Left Ventricular Dysfunction in Patients With Chronic Chagas Cardiomyopathy
by: Maykon Tavares de Oliveira, et al.
Published: (2021-09-01)

Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress
by: Xiaomo Wu, et al.
Published: (2020-08-01)

Galectin 3 and non-classical monocytes of blood as myocardial remodeling factors at ischemic cardiomyopathy
by: S. Chumakova, et al.
Published: (2021-04-01)

Scientometrics analysis of research activity and collaboration patterns in Chagas cardiomyopathy.
by: Gregorio González-Alcaide, et al.
Published: (2018-06-01)

Pathogenesis of chronic Chagas cardiomyopathy: the role of coronary microvascular derangements
by: Jose Antonio Marin-Neto, et al.
Published: (2013-09-01)

Controlled aggregation enhances immunomodulatory potential of mesenchymal stromal cell aggregates
by: Angela W. Xie, et al.
Published: (2021-08-01)